• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠视网膜色素上皮细胞上形成人膜攻击复合物的模型中,评估腺病毒递送的人CD59作为年龄相关性黄斑变性潜在治疗方法的效果。

Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.

作者信息

Ramo Kasmir, Cashman Siobhan M, Kumar-Singh Rajendra

机构信息

Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, USA.

出版信息

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4126-36. doi: 10.1167/iovs.08-2025. Epub 2008 May 16.

DOI:10.1167/iovs.08-2025
PMID:18487376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4139013/
Abstract

PURPOSE

Complement-mediated damage to the retinal pigment epithelium (RPE), Bruch membrane, and choroid has been associated with pathogenesis in age-related macular degeneration (AMD). The terminal step of complement activation involves lysis of cells by the insertion of the membrane attack complex (MAC) in the plasma membrane. The hypothesis that local overexpression of human CD59 (hCD59) delivered by an adenovirus (Ad) vector to primary murine RPE cells in vitro, RPE in vivo, or cornea ex vivo protects those cells from human MAC deposition and lysis was tested.

METHODS

A humanized model of MAC deposition on murine cells and murine ocular tissues including RPE and cornea was developed to permit testing of human complement regulators in mice. A recombinant adenovirus-expressing hCD59 was generated, and this virus was injected into the subretinal space of adult mice. Subsequently, eyecups from these mice were exposed to human serum, and the levels of MAC deposition on the RPE were quantified. hCD59 was also expressed on murine cornea ex vivo and in murine hepatocytes, and primary RPE cells in vitro and levels of human MAC deposition and cell lysis were measured.

RESULTS

Adenovirus-mediated delivery of hCD59 to the RPE, cornea, or cells in culture protects those cells from human MAC deposition and MAC-mediated damage and vesiculation.

CONCLUSIONS

The humanized model of MAC deposition on murine ocular tissues allows testing of human complement regulators that may have potential in the treatment of AMD or other diseases associated with complement activation.

摘要

目的

补体介导的对视网膜色素上皮(RPE)、 Bruch膜和脉络膜的损伤与年龄相关性黄斑变性(AMD)的发病机制有关。补体激活的终末步骤涉及膜攻击复合物(MAC)插入质膜导致细胞溶解。本研究测试了一种假说,即通过腺病毒(Ad)载体将人CD59(hCD59)在体外导入原代小鼠RPE细胞、在体内导入RPE或在体外导入角膜,可保护这些细胞免受人MAC沉积和溶解。

方法

建立了一种人源化的MAC在小鼠细胞和包括RPE及角膜在内的小鼠眼组织上沉积的模型,以允许在小鼠中测试人补体调节因子。构建了一种表达hCD59的重组腺病毒,并将该病毒注入成年小鼠的视网膜下间隙。随后,将这些小鼠的眼杯暴露于人类血清中,并对RPE上的MAC沉积水平进行定量。hCD59也在体外的小鼠角膜、小鼠肝细胞以及体外原代RPE细胞中表达,并检测人MAC沉积水平和细胞溶解情况。

结果

腺病毒介导的将hCD59递送至RPE、角膜或培养中的细胞,可保护这些细胞免受人MAC沉积以及MAC介导的损伤和囊泡形成。

结论

MAC在小鼠眼组织上沉积的人源化模型允许测试可能在治疗AMD或其他与补体激活相关疾病中具有潜力的人补体调节因子。

相似文献

1
Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.在小鼠视网膜色素上皮细胞上形成人膜攻击复合物的模型中,评估腺病毒递送的人CD59作为年龄相关性黄斑变性潜在治疗方法的效果。
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4126-36. doi: 10.1167/iovs.08-2025. Epub 2008 May 16.
2
A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration.一种非膜靶向的人源可溶性 CD59 可减轻年龄相关性黄斑变性模型中的脉络膜新生血管。
PLoS One. 2011 Apr 28;6(4):e19078. doi: 10.1371/journal.pone.0019078.
3
Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degeneration.衰变加速因子(CD55)介导的补体衰减:与年龄相关性黄斑变性相关的治疗意义。
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6776-83. doi: 10.1167/iovs.10-5887. Epub 2010 Aug 4.
4
Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration.腺病毒介导的 CD46 转导可减弱 RPE 上的替代补体途径:与年龄相关性黄斑变性的关系。
Gene Ther. 2011 Jun;18(6):613-21. doi: 10.1038/gt.2011.6. Epub 2011 Feb 10.
5
The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials.补体膜攻击复合物在干性和湿性 AMD 中的作用——从假设到临床试验。
Exp Eye Res. 2019 Jul;184:266-277. doi: 10.1016/j.exer.2019.05.006. Epub 2019 May 10.
6
New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.补体抑制剂CD59在小鼠激光诱导脉络膜新生血管形成中的新见解:损伤后的定位错误及蛋白质替代的靶向递送
J Ocul Pharmacol Ther. 2017 Jun;33(5):400-411. doi: 10.1089/jop.2016.0101. Epub 2017 Mar 23.
7
Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration.亚溶解 C5b-9 诱导视网膜色素上皮细胞功能改变,与年龄相关性黄斑变性一致。
Eye (Lond). 2011 Aug;25(8):1074-82. doi: 10.1038/eye.2011.109. Epub 2011 May 20.
8
Aurintricarboxylic acid inhibits complement activation, membrane attack complex, and choroidal neovascularization in a model of macular degeneration.金精三羧酸抑制补体激活、膜攻击复合物和脉络膜新生血管形成在黄斑变性模型。
Invest Ophthalmol Vis Sci. 2013 Oct 29;54(10):7107-14. doi: 10.1167/iovs.13-12923.
9
Topical application of PPADS inhibits complement activation and choroidal neovascularization in a model of age-related macular degeneration.在年龄相关性黄斑变性模型中,局部应用PPADS可抑制补体激活和脉络膜新生血管形成。
PLoS One. 2013 Oct 9;8(10):e76766. doi: 10.1371/journal.pone.0076766. eCollection 2013.
10
AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in mice.腺相关病毒介导的人 PRELP 表达抑制补体激活、脉络膜新生血管形成和膜攻击复合物在小鼠中的沉积。
Gene Ther. 2014 May;21(5):507-13. doi: 10.1038/gt.2014.24. Epub 2014 Mar 27.

引用本文的文献

1
Enhanced retinal pigment epithelial cells as a delivery vehicle for retinal disease.增强型视网膜色素上皮细胞作为视网膜疾病的递送载体。
Mol Ther Methods Clin Dev. 2025 Mar 14;33(2):101450. doi: 10.1016/j.omtm.2025.101450. eCollection 2025 Jun 12.
2
Plasma Glycated CD59 and Gestational Diabetes Mellitus: A Systematic Review.血浆糖化 CD59 与妊娠期糖尿病:系统综述。
Endocrinol Diabetes Metab. 2024 Nov;7(6):e70013. doi: 10.1002/edm2.70013.
3
CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex.CD59保护原代人脑血管平滑肌细胞免受溶细胞性膜攻击复合物的损伤。
Brain Sci. 2024 Jun 14;14(6):601. doi: 10.3390/brainsci14060601.
4
CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex.CD59保护原代人脑血管平滑肌细胞免受溶细胞性膜攻击复合物的损伤。
Res Sq. 2024 Apr 1:rs.3.rs-4165045. doi: 10.21203/rs.3.rs-4165045/v1.
5
AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies.基于 AAV 的视网膜和脉络膜血管疾病治疗策略:年龄相关性黄斑变性和糖尿病性视网膜病变治疗的新进展。
BioDrugs. 2024 Jan;38(1):73-93. doi: 10.1007/s40259-023-00629-y. Epub 2023 Oct 25.
6
Bruch's Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration.布鲁赫膜:年龄相关性黄斑变性基于补体疗法的关键考量因素
J Clin Med. 2023 Apr 14;12(8):2870. doi: 10.3390/jcm12082870.
7
Novel approach to antiangiogenic factors in age-related macular degeneration therapy.年龄相关性黄斑变性治疗中抗血管生成因子的新方法。
Cent Eur J Immunol. 2022;47(1):117-123. doi: 10.5114/ceji.2022.113103. Epub 2022 Feb 4.
8
Development of a Corneal Bioluminescence Mouse for Real-Time In Vivo Evaluation of Gene Therapies.用于基因治疗实时体内评估的角膜生物发光小鼠的开发。
Transl Vis Sci Technol. 2020 Dec 29;9(13):44. doi: 10.1167/tvst.9.13.44. eCollection 2020 Dec.
9
A Revised Hemodynamic Theory of Age-Related Macular Degeneration.年龄相关性黄斑变性的修正血流动力学理论
Trends Mol Med. 2016 Aug;22(8):656-670. doi: 10.1016/j.molmed.2016.06.009. Epub 2016 Jul 13.
10
Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.腺相关病毒介导的一种工程蛋白的递送,该工程蛋白结合了CD46、CD55和CD59的补体抑制特性。
J Gene Med. 2015 Jun-Jul;17(6-7):101-15. doi: 10.1002/jgm.2829.

本文引用的文献

1
The role of complement system in ocular diseases including uveitis and macular degeneration.补体系统在包括葡萄膜炎和黄斑变性在内的眼部疾病中的作用。
Mol Immunol. 2007 Sep;44(16):3901-8. doi: 10.1016/j.molimm.2007.06.145.
2
Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy.用于增殖性视网膜病变基因治疗的辅助依赖型腺病毒:稳定的基因转移、调控的基因表达及治疗效果。
J Gene Med. 2007 Oct;9(10):862-74. doi: 10.1002/jgm.1083.
3
Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex.补体C5b-9复合物诱导的外向和内向囊泡形成的活细胞成像。
J Biol Chem. 2007 Oct 12;282(41):29977-86. doi: 10.1074/jbc.M703742200. Epub 2007 Jul 20.
4
Complement C3 variant and the risk of age-related macular degeneration.补体C3变体与年龄相关性黄斑变性的风险
N Engl J Med. 2007 Aug 9;357(6):553-61. doi: 10.1056/NEJMoa072618. Epub 2007 Jul 18.
5
Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.补体因子B和补体成分2变体在年龄相关性黄斑变性中的保护作用。
Hum Mol Genet. 2007 Aug 15;16(16):1986-92. doi: 10.1093/hmg/ddm146. Epub 2007 Jun 18.
6
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.年龄相关性黄斑变性的15年累积发病率:比弗迪尔姆眼科研究
Ophthalmology. 2007 Feb;114(2):253-62. doi: 10.1016/j.ophtha.2006.10.040.
7
CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration.CD59是一种补体调节蛋白,在湿性年龄相关性黄斑变性小鼠模型中控制脉络膜新生血管形成。
J Immunol. 2007 Feb 1;178(3):1783-90. doi: 10.4049/jimmunol.178.3.1783.
8
Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium.A2E(视网膜色素上皮细胞脂褐质的一种成分)的光氧化产物激活补体。
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16182-7. doi: 10.1073/pnas.0604255103. Epub 2006 Oct 23.
9
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H.通过替代途径的补体激活在激光诱导的脉络膜新生血管形成中起关键作用:B因子和H因子的作用。
J Immunol. 2006 Aug 1;177(3):1872-8. doi: 10.4049/jimmunol.177.3.1872.
10
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.补体B因子(BF)和补体成分2(C2)基因的变异与年龄相关性黄斑变性有关。
Nat Genet. 2006 Apr;38(4):458-62. doi: 10.1038/ng1750. Epub 2006 Mar 5.